Core Laboratories Nv Stock Price To Earnings To Growth
| CLB Stock | USD 21.28 0.16 0.76% |
Core Laboratories NV fundamentals help investors to digest information that contributes to Core Laboratories' financial success or failures. It also enables traders to predict the movement of Core Stock. The fundamental analysis module provides a way to measure Core Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Laboratories stock.
Core | Price To Earnings To Growth |
Core Laboratories NV Company Price To Earnings To Growth Analysis
Core Laboratories' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Core Laboratories Price To Earnings To Growth | 1.90 X |
Most of Core Laboratories' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Core Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Core Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Core Laboratories NV has a Price To Earnings To Growth of 1.904 times. This is 89.21% lower than that of the Energy Equipment & Services sector and 70.93% lower than that of the Energy industry. The price to earnings to growth for all United States stocks is 61.06% higher than that of the company.
Core Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.Core Laboratories is currently under evaluation in price to earnings to growth category among its peers.
Core Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Core Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Core Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
Core Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0589 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 46.95 M | ||||
| Shares Owned By Insiders | 0.85 % | ||||
| Shares Owned By Institutions | 99.15 % | ||||
| Number Of Shares Shorted | 6.95 M | ||||
| Price To Earning | 101.74 X | ||||
| Price To Book | 3.98 X | ||||
| Price To Sales | 1.91 X | ||||
| Revenue | 509.79 M | ||||
| Gross Profit | 96.08 M | ||||
| EBITDA | 70.42 M | ||||
| Net Income | 37.02 M | ||||
| Cash And Equivalents | 15.43 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 215.38 M | ||||
| Debt To Equity | 1.29 % | ||||
| Current Ratio | 2.23 X | ||||
| Book Value Per Share | 5.34 X | ||||
| Cash Flow From Operations | 24.79 M | ||||
| Short Ratio | 21.39 X | ||||
| Earnings Per Share | 0.54 X | ||||
| Price To Earnings To Growth | 1.90 X | ||||
| Target Price | 20.0 | ||||
| Number Of Employees | 3.5 K | ||||
| Beta | 2.36 | ||||
| Market Capitalization | 999.1 M | ||||
| Total Asset | 586.39 M | ||||
| Retained Earnings | 120.76 M | ||||
| Working Capital | 135.04 M | ||||
| Current Asset | 238.55 M | ||||
| Current Liabilities | 120.76 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 2.66 % | ||||
| Net Asset | 586.39 M | ||||
| Last Dividend Paid | 0.04 |
About Core Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.316 | Dividend Share 0.04 | Earnings Share 0.54 | Revenue Per Share 11.158 | Quarterly Revenue Growth 0.072 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.